Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Randomized Trial Comparing Routine Use of the ActiValve to Standard Voice Prostheses

NCT: NCT07369050 · NOT_YET_RECRUITING

NCT IDNCT07369050
StatusNOT_YET_RECRUITING
Start Date2026-12-01
Completion2030-09-01
SponsorM.D. Anderson Cancer Center (OTHER)
First posted
Last updated

Brief Summary

The goal of this clinical research study is to learn if regular use of Provox® ActiValve® by patients after a total laryngectomy with TEP can decrease the number of VP device replacements needed annually.

Frequently Asked Questions

What is A Randomized Trial Comparing Routine Use of the ActiValve to Standard Voice Prostheses?

A Randomized Trial Comparing Routine Use of the ActiValve to Standard Voice Prostheses is a clinical trial registered under NCT07369050. Current status: NOT_YET_RECRUITING.

What is the status of NCT07369050?

The current status of NCT07369050 (A Randomized Trial Comparing Routine Use of the ActiValve to Standard Voice Prostheses) is: NOT_YET_RECRUITING.

When did A Randomized Trial Comparing Routine Use of the ActiValve to Standard Voice Prostheses start?

A Randomized Trial Comparing Routine Use of the ActiValve to Standard Voice Prostheses started on 2026-12-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑